FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1928889319> ?p ?o ?g. }

• W1928889319 endingPage "5173" @default.
• W1928889319 startingPage "5164" @default.
• W1928889319 abstract "Anti-gangliotetraosylceramide (anti-asialo GM1) and antiparagloboside monoclonal antibodies (MAbs) were used in immunofluorescence, immunoelectron-microscopic, and in vitro binding inhibition assays to determine whether either of the glycolipids was detectable in the normal cornea, whether levels changed following corneal scarification and either trypsin treatment or incubation in vitro with Pseudomonas aeruginosa, and whether either of the MAbs could competitively inhibit P. aeruginosa binding to cornea. No immunostaining above background for either glycolipid was observed in frozen, unfixed sections or in lightly fixed, K4M-embedded antibody-gold-labeled thin sections of normal cornea. In frozen sections of organ-cultured scarified cornea, no increased immunostaining for anti-asialo GM1 or antiparagloboside reactivity was noted immediately or 60 min after corneal scarification. However, at 60 min after scarification and in vitro incubation of the eye with either trypsin or P. aeruginosa, enhanced immunostaining for both glycolipids was associated with cells within or immediately adjacent to the wound site. Trypsin increased immunoreactivity in the wound site more markedly compared with incubation with P. aeruginosa, but immunostaining was similarly localized with either treatment. No staining above background was seen in control sections. Similarly, with immunoelectron microscopy, increased immunogold-MAb staining for both glycolipids was seen on the plasma membranes of the wound-site cells of eyes incubated with either trypsin or P. aeruginosa compared with controls that were similarly immunostained but with the primary antibody either omitted or substituted with a nonspecific MAb. Competitive binding inhibition assays, in which the bacterial inoculum or the eye in organ culture was incubated with anti-asialo GM1 MAb prior to topical ocular application of the bacteria, showed significantly decreased P. aeruginosa adhesion compared with preparations similarly treated with phosphate-buffered saline or antiparagloboside MAb. These data provide evidence to support the hypothesis that asialo GM1, not paragloboside, serves as a receptor for P. aeruginosa binding to the scarified cornea of the adult mouse and spatially localizes both glycolipids in the wound site." @default.
• W1928889319 created "2016-06-24" @default.
• W1928889319 creator A5022062069 @default.
• W1928889319 creator A5053675854 @default.
• W1928889319 creator A5063834104 @default.
• W1928889319 creator A5078971277 @default.
• W1928889319 date "1993-12-01" @default.
• W1928889319 modified "2023-09-30" @default.
• W1928889319 title "Evidence for asialo GM1 as a corneal glycolipid receptor for Pseudomonas aeruginosa adhesion" @default.
• W1928889319 cites W112973296 @default.
• W1928889319 cites W1659643892 @default.
• W1928889319 cites W1766993917 @default.
• W1928889319 cites W1769763311 @default.
• W1928889319 cites W1858155948 @default.
• W1928889319 cites W1898218638 @default.
• W1928889319 cites W1905817031 @default.
• W1928889319 cites W1971932849 @default.
• W1928889319 cites W1979158308 @default.
• W1928889319 cites W2024438074 @default.
• W1928889319 cites W2030008965 @default.
• W1928889319 cites W2035072639 @default.
• W1928889319 cites W2059132394 @default.
• W1928889319 cites W2060183661 @default.
• W1928889319 cites W2062973078 @default.
• W1928889319 cites W2064535843 @default.
• W1928889319 cites W2066889698 @default.
• W1928889319 cites W2089015231 @default.
• W1928889319 cites W2117764526 @default.
• W1928889319 cites W2123156755 @default.
• W1928889319 cites W2137065713 @default.
• W1928889319 cites W2164620775 @default.
• W1928889319 cites W2282282089 @default.
• W1928889319 cites W2285022203 @default.
• W1928889319 cites W2293429461 @default.
• W1928889319 cites W2415864831 @default.
• W1928889319 cites W34364097 @default.
• W1928889319 cites W4692725 @default.
• W1928889319 cites W59111121 @default.
• W1928889319 cites W94542197 @default.
• W1928889319 cites W1982937774 @default.
• W1928889319 doi "https://doi.org/10.1128/iai.61.12.5164-5173.1993" @default.
• W1928889319 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/281297" @default.
• W1928889319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8225593" @default.
• W1928889319 hasPublicationYear "1993" @default.
• W1928889319 type Work @default.
• W1928889319 sameAs 1928889319 @default.
• W1928889319 citedByCount "51" @default.
• W1928889319 countsByYear W19288893192013 @default.
• W1928889319 countsByYear W19288893192014 @default.
• W1928889319 countsByYear W19288893192015 @default.
• W1928889319 countsByYear W19288893192017 @default.
• W1928889319 countsByYear W19288893192018 @default.
• W1928889319 countsByYear W19288893192020 @default.
• W1928889319 countsByYear W19288893192021 @default.
• W1928889319 countsByYear W19288893192022 @default.
• W1928889319 crossrefType "journal-article" @default.
• W1928889319 hasAuthorship W1928889319A5022062069 @default.
• W1928889319 hasAuthorship W1928889319A5053675854 @default.
• W1928889319 hasAuthorship W1928889319A5063834104 @default.
• W1928889319 hasAuthorship W1928889319A5078971277 @default.
• W1928889319 hasBestOaLocation W19288893191 @default.
• W1928889319 hasConcept C153911025 @default.
• W1928889319 hasConcept C159654299 @default.
• W1928889319 hasConcept C169760540 @default.
• W1928889319 hasConcept C203014093 @default.
• W1928889319 hasConcept C204232928 @default.
• W1928889319 hasConcept C22222904 @default.
• W1928889319 hasConcept C2776882836 @default.
• W1928889319 hasConcept C2993140218 @default.
• W1928889319 hasConcept C30030713 @default.
• W1928889319 hasConcept C4224716 @default.
• W1928889319 hasConcept C54355233 @default.
• W1928889319 hasConcept C55493867 @default.
• W1928889319 hasConcept C74864618 @default.
• W1928889319 hasConcept C86803240 @default.
• W1928889319 hasConcept C89423630 @default.
• W1928889319 hasConceptScore W1928889319C153911025 @default.
• W1928889319 hasConceptScore W1928889319C159654299 @default.
• W1928889319 hasConceptScore W1928889319C169760540 @default.
• W1928889319 hasConceptScore W1928889319C203014093 @default.
• W1928889319 hasConceptScore W1928889319C204232928 @default.
• W1928889319 hasConceptScore W1928889319C22222904 @default.
• W1928889319 hasConceptScore W1928889319C2776882836 @default.
• W1928889319 hasConceptScore W1928889319C2993140218 @default.
• W1928889319 hasConceptScore W1928889319C30030713 @default.
• W1928889319 hasConceptScore W1928889319C4224716 @default.
• W1928889319 hasConceptScore W1928889319C54355233 @default.
• W1928889319 hasConceptScore W1928889319C55493867 @default.
• W1928889319 hasConceptScore W1928889319C74864618 @default.
• W1928889319 hasConceptScore W1928889319C86803240 @default.
• W1928889319 hasConceptScore W1928889319C89423630 @default.
• W1928889319 hasIssue "12" @default.
• W1928889319 hasLocation W19288893191 @default.
• W1928889319 hasLocation W19288893192 @default.
• W1928889319 hasLocation W19288893193 @default.
• W1928889319 hasOpenAccess W1928889319 @default.
• W1928889319 hasPrimaryLocation W19288893191 @default.
• W1928889319 hasRelatedWork W1928889319 @default.

• next